相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations
Naseemap Gangat et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The Circulating Wound Model
Alessandro Lucchesi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Hemorrhage in Essential Thrombocythemia or Polycythemia Vera: Epidemiology, Location, Risk Factors, and Lessons Learned from the Literature
Christophe Nicol et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Hydroxyurea: a reappraisal of its cutaneous side effects and their management
Camille A. Bulte et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Peripheral arterial disease: Scoping review of patient-centred outcomes
Laura Bolton
INTERNATIONAL WOUND JOURNAL (2019)
Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
Alessandra Carobbio et al.
BLOOD ADVANCES (2019)
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Tiziano Barbuil et al.
LEUKEMIA (2018)
Incidence and impact of atrial arrhythmias on thrombotic events in MPNs
Kristell Mahe et al.
ANNALS OF HEMATOLOGY (2018)
Peripheral artery disease: epidemiology and global perspectives
F. Gerry R. Fowkes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Update on atrial fibrillation
Amanulla Khaji et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2017)
Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants
Ana Sofia de Freitas et al.
ANNALS OF HEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Prevalence of calreticulin exon 9 indel mutations in vascular risk patients
Thomas Jaeger et al.
THROMBOSIS RESEARCH (2016)
The Rotterdam Study: 2016 objectives and design update
Albert Hofman et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease
Axel Muendlein et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
Tiziano Barbui et al.
BLOOD (2012)
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia
Luigi Gugliotta et al.
LEUKEMIA RESEARCH (2011)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
分享论文
